MCAZ
Menu
Staff Email
FAQs
Whatsapp
Facebook
Twitter
Instagram
Linkedin
Youtube
Menu
Home
About Us
Who We Are
MCAZ Board Members
Careers @ MCAZ
Privacy Policy
Tenders
Corporate Governance
Board Charter
Client Service Charter
Our Strategic Plan
Regulatory Functions
Evaluation and Registration
Overview
Find A Registered Medicine
How to Register
Alternative Submission Pathways
Registered & Approved Medicines
Human Medicines Guidelines
Key timelines
Important Information
Summary of Product Characteristics
Licensing and Enforcement
Overview
Licensing
Inspections
Import & Export
Product Defects & Recalls
Medicinal Cannabis
Enquiries
Pharmacovigilance and Clinical Trials
Current Projects
Pharmacovigilance Centre
Clinical Trials
WHO Pharmacovigilance Toolkit
Clinical Trial Public Registry Platform
Laboratory Services
Medical Devices Laboratory
Microbiology Laboratory
Chemistry Laboratory
Legal and Coperate Affairs
Overview
Procurement Section
Tenders
Request For Quotations
Online Services
Online Registers
Import/Export for Registered Medicines
Section 75 Authorisation
Online Persons and Premises Renewals
ADR E-Reporting
Consumer Reporting
Healthcare Professional Reporting
e-Clinical Trials
Publications
Annual Reports
Press Release
Vaccine Safety
Downloads
RCore Trainings
Contact Us
PVF 55_Rev_3_July_2022_Submission_Declaration_by_Investigators
PVF 55_Rev_3_July_2022_Submission_Declaration_by_Investigators
422
Downloads
Download Now!
Size:
159KB
About the Author
Munya Jaravaza
Post navigation
PVF 01 Rev 9_September 2022 Spontaneous ADR Report Form
PVF 79 Rev_1 September 2022 Joint Declaration By Sponsor And Principal Investigator Sufficient Funds
You may also like these
No Related Post
